Lantheus Holdings, Inc. cotiza a 100.02 USD y tiene una capitalización bursátil de $6.5B. En los últimos 12 meses ha facturado $1.6B con un margen de flujo de caja libre del 23.0%. Cotiza a 16.8 veces su flujo de caja libre (P/FCF) y a un PER de 23.7. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a tec…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $1.55 | $1.46 | $1.67 |
| Estimado | $1.35 | $1.30 | $1.23 | $1.17 |
| Sorpresa | — | +19.2% | +18.7% | +42.7% |
| Métrica | LNTH | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 61.1% | 57.0% | +4.1% |
| Operating Margin | 20.2% | -38.6% | +58.8% |
| Net Margin | 15.2% | -33.6% | +48.7% |
| FCF Margin | 23.0% | -13.9% | +36.8% |
| ROE | 21.4% | -40.4% | +61.8% |
| ROA | 10.5% | -32.0% | +42.5% |
| Current Ratio | 2.70 | 2.84 | -0.14 |
| Debt / Equity | 0.52 | 0.28 | +0.24 |